Home Newsletters Mesenchymal Cell News Selective Histone Methyltransferase G9a Inhibition Reduces Metastatic Development of Ewing Sarcoma through...

Selective Histone Methyltransferase G9a Inhibition Reduces Metastatic Development of Ewing Sarcoma through the Epigenetic Regulation of NEU1

By

-

March 30, 2022

Researchers evaluated the effects of a selective G9a histone methyltransferase inhibitor on Ewing sarcoma metastatic process.

[Oncogene]

Sorry, but the selected Zotpress account can't be found.

Exit mobile version